Patents by Inventor Maki Matsubayashi

Maki Matsubayashi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040156847
    Abstract: Herein disclosed are therapeutic agents for hypereosinophilic diseases comprising a substance inducing eosinophil apoptosis via CD30 and/or a molecule involved in CD30 signal transduction as an active ingredient. Such therapeutic agents are effective for allergic diseases, respiratory diseases, skin diseases, autoimmune diseases, immunodeficiency diseases, digestive diseases, neoplastic diseases and parasitic infections.
    Type: Application
    Filed: December 19, 2003
    Publication date: August 12, 2004
    Applicants: DAIICHI SUNTORY PHARMA CO., LTD., DAIICHI SUNTORY BIOMEDICAL RESEARCH, LTD.
    Inventors: Kenju Miura, Maki Matsubayashi, Hirohisa Saito, Kenji Matsumoto